CTRI/2022/01/039176招募中3 期
Evaluation of the efficacy and safety of Joint Support Product (GP/PROD/2021/002) in knee osteoarthritis: A randomized, double-blind, Placebo controlled clinicalstudy. - Nil
Mr Kamlesh Thummar0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Male and/or female volunteers aged between 40 to 80 years both inclusive.
- •BMI ( ââ?°Â¥) greater than or equal to 24 Kg/m2 and less than or equal to (ââ?°Â¤) 38 Kg/m2
- •Willing to follow the diet advised by investigator
- •Willing to come for regular follow-up visits.
- •Patients diagnosed clinically with osteoarthritis of the knee based on the American College of Rheumatology (ACR) criteria.
排除标准
- •Patients with congenital arthropathy, rheumatoid arthritis, active gout, other type of arthritis with/without inflammation e.g. septic, fibromyalgia or collagen vascular disease
- •Patients with known history of coagulopathies
- •Osteoarthritis of any other joint except knee
- •Patients with history of major trauma or surgery in the knee joint
- •Patients with uncontrolled diabetes and hypertension
- •Body mass index (BMI) >38 kg/m2.
- •Patients with any severe cardiac, renal and hepatic disease
- •Pregnant and lactating women
- •Patients who participated in any clinical trial within 30 days
- •before enrollment into the study
- •Any other condition which the Principal Investigator thinks
- •may jeopardize the study
研究者
相似试验
已完成
不适用
A clinical study to determine the safety, a combined effect of probiotics and Senna combined the Test product, ââ?¬Ë?M Sip LaxTMââ?¬â?¢ Straw in Healthy Human Subjects Affected By Functional ConstipatioCTRI/2022/02/040158Inzpera Healthsciences Limited16
招募中
Unknown
A clinical trial to study and compare two minimal invasive stone removal procedures for kidney stones, mini PCNL with attached suction vs standard mini PCCTRI/2023/03/050337Pushpanjali hospital and research centre
已完成
2 期
A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel with MORAb-004 in Metastatic Soft Tissue Sarcomasoft tissue cancer10072990NL-OMON39691Morphotek, Inc10
进行中（未招募）
1 期
A clinical trial that is evaluating how safe and effective an experimental treatment called MORAb-004 is when used in combination with Gemcitabine and Docetaxel in patients diagnosed with Metastatic Soft Tissue Sarcoma.EUCTR2012-001399-12-NLMorphotek Inc.200
进行中（未招募）
1 期
A clinical trial that is evaluating how safe and effective an experimental treatment called MORAb-004 is when used in combination with Gemcitabine and Docetaxel in patients diagnosed with Metastatic Soft Tissue Sarcoma.Metastatic Soft Tissue SarcomaMedDRA version: 15.1Level: HLGTClassification code 10041299Term: Soft tissue sarcomasSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-001399-12-BEMorphotek Inc.200